Myeloma, Multiple Clinical Trials in Philadelphia, Pennsylvania
2 recruitingPhiladelphia, Pennsylvania
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Multiple MyelomaMyelomaMyeloma, Multiple
K36 Therapeutics, Inc.165 enrolled22 locationsNCT05651932
Recruiting
Phase 2
Limited-duration Teclistamab
Myeloma, Multiple
Abramson Cancer Center at Penn Medicine75 enrolled5 locationsNCT05932680